PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Medical pros of electroconvulsive therapy (ECT) exaggerated while cons downplayed, survey findings suggest

Patients nearly 4 times more likely to recall being told of short rather than long-term memory loss and 6 times more likely to recall being told ECT can be life saving rather than about potential heart problems

2025-08-14
(Press-News.org) The medical pros of electroconvulsive therapy (ECT) are being exaggerated while the risks are being downplayed, suggest the findings of a survey on the type of information patients and their relatives/friends recall having been given before the procedure, and published online in the Journal of Medical Ethics.

Based on the responses, the researchers calculate that patients were nearly 4 times more likely to recall being told that resulting memory problems were temporary rather than long term. And they were 6 times more likely to recall being told that ECT can be life-saving rather than about potential heart problems.

ECT involves inducing a brief, controlled seizure in the brain using electrical currents, usually given in 6 to 12 treatments under general anesthesia over several weeks, explain the researchers.

Since its invention in 1938, ECT has remained a controversial procedure. And there is still no consensus on its medical pros and cons, exactly how it works–and for which mental health conditions—or the optimal dosing protocol, they add.

In 2023, a joint report by the World Health Organization (WHO) and the United Nations confirmed that anyone offered ECT should be made aware of all its risks and potential short- and long-term risks, such as memory loss and brain damage.

But recent audits of patient information leaflets on ECT in Australia and from across the UK suggest that the effectiveness of the treatment is often exaggerated while the risks are minimised, note the researchers.

To find out what ECT recipients, and their relatives/friends, recall being told about the procedure, the researchers drew on the survey responses of a convenience sample of 858 ECT recipients and 286 relatives and friends from 44 countries, completed between January and September 2024.

Most respondents were White and female. The average age at the time of their last ECT was 41, but ranged from 12 to 87. Most ECT recipients (73%) had their last ECT between 2010 and 2024. But for around 2% this dated back to between 1950 and 1969.

The reasons given for the treatment included depression (73%); psychosis/schizophrenia (17%); bipolar disorder/mania (15%); catatonia (8%); other (13%); and ‘don’t know’ (6%).

Respondents were asked if they remembered having been informed about the possible side effects of ECT, principally heart problems; temporary and long term memory problems, including greater susceptibility to these among women and older people; and the cognitive risks associated with serial general anaesthesia. 

They were also asked if they remembered having been informed about their legal rights in relation to ECT, including that there’s no evidence ECT has any long-term benefits.

And they were asked if they recalled being told (and misinformed) that: depression is caused by a chemical imbalance in the brain; ECT corrects this and other brain abnormalities; ECT can be life-saving/prevents suicide; it’s the most effective treatment for severe depression 

Of the 735 ECT recipients who answered the question about the adequacy of the information received before the procedure, over half (59%) said this wasn’t adequate while 17% weren’t sure. 

For example, nearly two thirds (63%) recall being told that ’ECT can cause temporary memory problems’, but only 17% that it ‘can cause long term or permanent memory problems’. 

Only 12% recall being told that ’ECT can cause heart problems’ and 28% that there are ’risks from repeated general anaesthesia’. 

There were higher levels of recall around the information given about the definite benefits of ECT, although some of these benefits are disputed, say the researchers. 

When asked to consider a list of items of misinformation, many recipients and relatives recall being told ’depression is caused by a chemical imbalance in the brain’ (58% and 53%, respectively) and that ’ECT corrects chemical imbalance or other brain abnormality’ (42% and 41%, respectively).

Based on 682 ECT recipients who recalled at least one piece of information, the researchers calculated that they were nearly 4 times more likely to remember having been told about temporary memory problems as they were to have been told about long-term or permanent memory problems. 

They were more than 5 times as likely to recall having been told ECT is the most effective treatment for severe depression as they were that there’s no evidence for any long-term benefits. And they were 6 times more likely to remember having been told that ECT can be ‘life saving/prevents suicide’ as they were about potential heart problems.

Everyone was invited to include up to two other things they recalled clinicians telling them about ECT, if any: 363 ECT recipients, and 37 family/friends did so. The most common information reported (154 recipients and 11 family/friends) involved minimising memory loss or other side effects in various ways. 

This included denial of any long-term effects (51) or simply stating that ECT is safe (34). Fifty one respondents recall being told ECT was the only option left for recovery, mostly because psychiatric drugs hadn’t worked. 

This is a convenience sample and the researchers acknowledge that it may therefore not be representative of all ECT recipients. And those who were dissatisfied with their experience might have been more likely to fill in the survey.

The responses also relied on personal recall, which, in a few cases, dated back to the 1950s. And events in the period just before ECT are particularly vulnerable to being lost because of the ECT, caution the researchers.

Nevertheless, the findings align with those of previous studies, they point out. “The minimisation of risks, particularly long-term adverse effects, was pronounced, in both our quantitative and qualitative data,” they highlight, adding: “The legal implications of not ensuring informed consent are substantial.”

They conclude: “These findings, in conjunction with previous studies, suggest an urgent need for greater efforts to ensure that patients and families are provided with comprehensive, balanced, evidence-based information when deciding whether to have ECT.”

They suggest: “If efforts to persuade hospitals and clinics to comply with the ethical principIe of informed consent by providing balanced, comprehensive, evidence-based information are unsuccessful, professional, regulatory, and government organisations should intervene.”

END


ELSE PRESS RELEASES FROM THIS DATE:

Experts recommend SGLT-2 and GLP-1 diabetes drugs only for adults at moderate to higher risk of heart and kidney problems

2025-08-14
SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher risk of cardiovascular and kidney complications, and in the majority of adults at moderate risk of complications, say a panel of international experts in The BMJ today. But for those at lower risk, they advise against routinely recommending these drugs, and suggest doctors discuss treatment options with their patients, noting that decisions are likely to be more contextual and based on what’s most important to the individual.  For ...

Global study finds heart failure drug spironolactone fails to lower cardiovascular risk in dialysis patients

2025-08-14
A large international study has found that spironolactone, a medication for high blood pressure and heart failure, does not reduce the risk of heart-related death or hospitalizations in people with kidney failure receiving dialysis, despite earlier smaller studies suggesting benefit. The findings were published on August 14 in The Lancet and presented at ERA Congress 2025. The study enrolled 2,538 participants from 143 dialysis centres across 12 countries, making it the largest trial to date on spironolactone ...

Deprivation and transport density linked to increased suicide risk in England

2025-08-14
*Embargoed links to the paper, regional data, and additional quotes are available at the end of this press release*  IMPERIAL COLLEGE LONDON PRESS RELEASE Peer Reviewed / Observational study / People                        An analysis of suicide rates in England has shown how factors like deprivation and transport density are linked to regional increases in suicide risk. The first of its kind study, led by researchers at Imperial College London, UCL and the London School of Economics and Political Science (LSE), looked at suicide trends in England from 2002 to 2022 combined with the ...

Flatworms can replace rats for breakthrough brain studies

2025-08-14
Tiny pond worms could help find new ways to treat schizophrenia, develop understanding around drug addiction and test new medicines for mental illnesses – all while reducing the number of mice and rats used in early medical research.  Scientists from the University of Reading say that planaria - harmless flatworms found in ponds and rivers - react to brain medicines in ways similar to rodents. When given haloperidol, a drug used to treat mental health conditions, the worms became much less active, ...

Plastic from plants: FAMU-FSU College of Engineering professor uses material in plant cell walls to make versatile polymer

2025-08-14
In Ho Yong Chung’s laboratory, magic is at work — plants turn into plastics. In new research, Chung, an associate professor in the FAMU-FSU College of Engineering, showed for the first time the possibility of using lignin, a material found in plant cell walls, and carbon dioxide to create a new kind of polyurethane, a polymer used in various applications for its ability to regulate heat, flexibility during processing and strength as a finished product. The work was published in ACS Sustainable Chemistry & Engineering. “We’ve ...

Leaders at Huntsman Cancer Institute drive theranostics expansion to transform cancer care

2025-08-14
Huntsman Cancer Institute at the University of Utah (the U) announces leadership team appointments overseeing clinical and research efforts in theranostics, an innovative approach to radiation treatment for cancer that combines diagnostics and therapeutics.  Heloisa Soares, MD, PhD, Huntsman Cancer Institute medical oncologist and associate professor of internal medicine at the U, will serve as medical director of the theranostics program.  Theranostics is a powerful new way to both find and treat cancer. It uses radioactive drugs—called radiopharmaceuticals—that ...

Thin films, big science: FSU chemists expand imaging possibilities with new X-ray material

2025-08-14
Most people picture a doctor checking for a broken bone when they think of an X-ray. But the technology is just as important in places like airport security, manufacturing, quality control and scientific research, each with its own criteria for size and shape.  A team led by Florida State University Professor of Chemistry and Biochemistry Biwu Ma has developed a new form for X-ray materials that can meet the needs of large-area applications, changing out complex crystal structures for an adaptable and scalable thin-film detector. The work was published in Angewandte Chemie.  “We took a material we developed and made it better,” Ma said. “This ...

66th Supplement to the Check-list of North American Birds publishes today in Ornithology

2025-08-14
CHICAGO — August 14, 2025  — The 66th Supplement to the American Ornithological Society’s (AOS’s) Check-list of North American Birds, published today in Ornithology, includes several significant updates to the classification of bird species found in North America, Central America, and the Caribbean. A few highlights from the supplement, detailed below, include species splits for Myiarchus nuttingi, Vireo gilvus, and Larus argentatus; the addition of subfamilies in the Laridae for white-terns and noddies; and a merging of three families ...

Canadian crops beat global emissions—even after 17 trips across the Atlantic

2025-08-14
Canadian-grown wheat, canola and peas have some of the lowest carbon footprints in the world—so low that, in some cases, they could be shipped to Europe 17 times before matching the emissions of the same crops grown there.  The study out of UBC Okanagan, published in Nature Food, compared the carbon footprints of these crops from Canada, France, Germany, Australia and the United States using the ISO 14067 standard.   Led by Dr. Nicole Bamber of UBCO’s Irving K. Barber Faculty of Science, the research ...

ORC2 regulation of human gene expression shows unexpected breadth and scale

2025-08-14
BIRMINGHAM, Ala. – Origin-recognition complex, or ORC, plays an unexpectedly broad role in the regulation of human cell gene expression, according to a study in the journal Cell Reports. “This is the first detailed study of how and where ORC regulates epigenetics and gene expression in human cells,” said Anindya Dutta, Ph.D., leader of the study and chair of the University of Alabama at Birmingham Department of Genetics. “The unanticipated scale and breadth of the regulation opens new chapters in ORC biology.” The six-subunit complex was discovered ...

LAST 30 PRESS RELEASES:

New CRISPR technique could rewrite future of genetic disease treatment

he new tech that could improve care for Parkinson's patients

Sharing is power: do the neighbourly thing when it comes to solar

Sparring saigas win 2025 BMC journals Image Competition

Researchers discover dementia-like behaviour in pre-cancer cells

Medical pros of electroconvulsive therapy (ECT) exaggerated while cons downplayed, survey findings suggest

Experts recommend SGLT-2 and GLP-1 diabetes drugs only for adults at moderate to higher risk of heart and kidney problems

Global study finds heart failure drug spironolactone fails to lower cardiovascular risk in dialysis patients

Deprivation and transport density linked to increased suicide risk in England

Flatworms can replace rats for breakthrough brain studies

Plastic from plants: FAMU-FSU College of Engineering professor uses material in plant cell walls to make versatile polymer

Leaders at Huntsman Cancer Institute drive theranostics expansion to transform cancer care

Thin films, big science: FSU chemists expand imaging possibilities with new X-ray material

66th Supplement to the Check-list of North American Birds publishes today in Ornithology

Canadian crops beat global emissions—even after 17 trips across the Atlantic

ORC2 regulation of human gene expression shows unexpected breadth and scale

Researchers track how iron deficiency disrupts photosynthesis in crucial ocean algae

A Mount Sinai-Led team creates model for understanding how the brain’s decision-making is impacted in psychiatric disorders

A new way to study omega fatty acids

Targeting ferroptosis in cancer stem cells: A promising approach to enhance cancer treatment

As the atmosphere changes, so will its response to geomagnetic storms

First transfer of behavior between species through single gene manipulation

A new network could help predict health problems in your pup

Connecting biofuel and conservation policies

Deep learning model successfully predicted ignition in inertial confinement fusion experiment

Maternal antibodies in breast milk regulate early immune responses in mouse gut

Densely planted maize communicates with neighboring plants to defend against pests

Paper: Decarbonize agriculture by expanding policies aimed at low-carbon biofuels

New tech speeds up AI training for drug discovery/disease research

Researchers synthesize a new allotrope of carbon

[Press-News.org] Medical pros of electroconvulsive therapy (ECT) exaggerated while cons downplayed, survey findings suggest
Patients nearly 4 times more likely to recall being told of short rather than long-term memory loss and 6 times more likely to recall being told ECT can be life saving rather than about potential heart problems